Keros Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Keros Therapeutics, Inc. (KROS) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-03
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $0.00.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$9.00K, a 550.00% decline year-over-year.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $5.00K.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $599.00K, a 698.67% increase from fiscal 2022.
- Keros Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $75.00K, a 581.82% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | $0.00 derived: sum of 3 quarters · filed 2026-08-03 | -$9.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | -$9.00K derived: sum of 3 quarters · filed 2026-05-14 | -$10.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$9.00K derived: sum of 2 quarters · filed 2026-03-04 | -$10.00K derived: sum of 3 quarters · filed 2026-08-03 | $5.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$10.00K derived: sum of 2 quarters · filed 2026-08-03 | $5.00K 10-Q · filed 2025-11-05 | -$81.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $14.00K 10-Q · filed 2026-08-03 | -$72.00K derived: sum of 3 quarters · filed 2026-08-03 | -$70.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $15.00K 10-Q · filed 2026-05-14 | -$71.00K derived: sum of 2 quarters · filed 2026-05-14 | -$69.00K derived: sum of 3 quarters · filed 2026-05-14 | -$215.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$84.00K derived: sum of 2 quarters · filed 2026-03-04 | -$230.00K derived: sum of 3 quarters · filed 2026-03-04 | $0.00 10-K · filed 2026-03-04 |
| 2024-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$144.00K derived: sum of 2 quarters · filed 2025-11-05 | $86.00K 10-Q · filed 2025-11-05 | $625.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $84.00K 10-Q · filed 2025-08-06 | $623.00K derived: sum of 3 quarters · filed 2025-08-06 | $628.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $230.00K 10-Q · filed 2025-05-06 | $769.00K derived: sum of 2 quarters · filed 2025-05-06 | $774.00K derived: sum of 3 quarters · filed 2025-05-06 | $808.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $544.00K derived: sum of 2 quarters · filed 2025-02-26 | $578.00K derived: sum of 3 quarters · filed 2025-02-26 | $599.00K 10-K · filed 2025-02-26 |
| 2023-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $39.00K derived: sum of 2 quarters · filed 2024-11-06 | $60.00K 10-Q · filed 2024-11-06 | $122.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $55.00K 10-Q · filed 2024-08-07 | $117.00K derived: sum of 3 quarters · filed 2025-02-26 | $106.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $21.00K 10-Q · filed 2024-05-08 | $83.00K derived: sum of 2 quarters · filed 2025-02-26 | $72.00K derived: sum of 3 quarters · filed 2025-02-26 | $9.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $51.00K derived: sum of 2 quarters · filed 2025-02-26 | -$12.00K derived: sum of 3 quarters · filed 2025-02-26 | $75.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$74.00K derived: sum of 2 quarters · filed 2023-11-06 | $13.00K 10-Q · filed 2023-11-06 | -$111.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $24.00K 10-Q · filed 2023-08-07 | -$100.00K derived: sum of 3 quarters · filed 2024-02-28 | $35.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $87.00K 10-Q · filed 2023-05-04 | -$37.00K derived: sum of 2 quarters · filed 2024-02-28 | $98.00K derived: sum of 3 quarters · filed 2024-02-28 | $98.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $11.00K derived: sum of 2 quarters · filed 2024-02-28 | $11.00K derived: sum of 3 quarters · filed 2024-02-28 | $11.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $135.00K derived: sum of 2 quarters · filed 2022-11-03 | $135.00K 10-Q · filed 2022-11-03 | $135.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 3 quarters · filed 2022-08-04 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $0.00 10-K · filed 2022-03-09 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |